← Open Payments lookup

JESSICA CARR: Open Payments

NPI 1225507528 · ABINGDON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,201 in 63 payments from 17 companies in 2025. Trend: 2023 $56 · 2024 $445 · 2025 $1,201

Food & beverage: $1,201
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$295
Vanda Pharmaceuticals Inc.7$187
ABBVIE INC.14$179
Novartis Pharmaceuticals Corporation4$92
Esperion Therapeutics, Inc.5$85
PFIZER INC.3$51
Takeda Pharmaceuticals U.S.A., Inc.3$50
Alkermes, Inc.2$48
Amgen Inc.2$35
Sumitomo Pharma America, Inc.2$33

Products named: CAPLYTA, FANAPT, LEQVIO, NEXLETOL, VRAYLAR, QULIPTA, TRINTELLIX, LYBALVI.

Industry payments across VA — which companies pay providers there.